Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Contribution of Gut-Brain Axis to Development of Neurological Symptoms in Covid-19 Recovered Patients: A Hypothesis and Review of Literature Publisher Pubmed



Vakili K1 ; Fathi M1 ; Yaghoobpoor S1 ; Sayehmiri F1 ; Nazerian Y2 ; Nazerian A3 ; Mohamadkhani A4 ; Khodabakhsh P5 ; Reus GZ6 ; Hajibeygi R7 ; Rezaeitavirani M8
Authors

Source: Frontiers in Cellular and Infection Microbiology Published:2022


Abstract

The gut microbiota undergoes significant alterations in response to viral infections, particularly the novel SARS-CoV-2. As impaired gut microbiota can trigger numerous neurological disorders, we suggest that the long-term neurological symptoms of COVID-19 may be related to intestinal microbiota disorders in these patients. Thus, we have gathered available information on how the virus can affect the microbiota of gastrointestinal systems, both in the acute and the recovery phase of the disease, and described several mechanisms through which this gut dysbiosis can lead to long-term neurological disorders, such as Guillain-Barre syndrome, chronic fatigue, psychiatric disorders such as depression and anxiety, and even neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. These mechanisms may be mediated by inflammatory cytokines, as well as certain chemicals such as gastrointestinal hormones (e.g., CCK), neurotransmitters (e.g., 5-HT), etc. (e.g., short-chain fatty acids), and the autonomic nervous system. In addition to the direct influences of the virus, repurposed medications used for COVID-19 patients can also play a role in gut dysbiosis. In conclusion, although there are many dark spots in our current knowledge of the mechanism of COVID-19-related gut-brain axis disturbance, based on available evidence, we can hypothesize that these two phenomena are more than just a coincidence and highly recommend large-scale epidemiologic studies in the future. Copyright © 2022 Vakili, Fathi, Yaghoobpoor, Sayehmiri, Nazerian, Nazerian, Mohamadkhani, Khodabakhsh, Reus, Hajibeygi and Rezaei-Tavirani.
Other Related Docs
5. Gut-Brain Axis and Migraine Headache: A Comprehensive Review, Journal of Headache and Pain (2020)
8. Gut Microbiota Might Act As a Potential Therapeutic Pathway in Covid-19, Current Pharmaceutical Biotechnology (2022)
12. Gut Microbiome in Multiple Sclerosis-Related Cognitive Impairment, Multiple Sclerosis and Related Disorders (2022)
13. The Interplay Between Gut Microbiota and Autism Spectrum Disorders: A Focus on Immunological Pathways, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
15. Exploring the Effect of Gut Microbiome on Alzheimer's Disease, Biochemistry and Biophysics Reports (2024)